SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
Sang Soo Kim(Georgetown University Medical Center), Esther H. Chang(Georgetown University)
Cited by 6
Related Papers
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
|Nucleic Acids Research|2017|123
A tumor‐targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti‐PD‐1 immunotherapy in mouse models of glioblastoma
|International Journal of Cancer|2019|65